Diclofenac Sodium Enteric-Coated Tablets

The main ingredient of this product is diclofenac sodium. Its chemical name is [o-(2,6-dichloroaniline)]phenylacetic acid sodium. Chemical name: [o-(2,6-dichloroaniline)]phenylacetic acid

This product is enteric-coated tablets, which appear white after removing the enteric coating.

(1) As a routine dose, the initial daily dose is 100mg-150mg (4-6 tablets). For mild patients or patients requiring long-term treatment, the daily dose is 75-100mg (3-4 tablets). The daily dose is usually taken in 2-3 divided doses. (2) For primary dysmenorrhea, the daily dose is usually 50-150mg (2-6 tablets), taken in divided doses. The initial dose should be 50-150mg (2-6 tablets). If necessary, the dose can be increased within several menstrual cycles to a maximum dose of 200mg/day. Once symptoms appear, treatment should be started immediately and continued for several days. The treatment plan depends on the symptoms. (3) Common dosage for children: 0.5-2.0mg/kg per day, the maximum daily dose is 3.0mg/kg, taken in 3 divided doses.

① Gastrointestinal reaction: the most common adverse reaction, which occurs in about 10% of patients. It mainly includes stomach discomfort, burning sensation, acid reflux, poor appetite, nausea, etc., which can disappear after stopping the drug or symptomatic treatment. A few of them may have ulcers, bleeding, and perforation; ② Nervous system manifestations include headache, dizziness, drowsiness, excitement, etc.; ③ It causes edema, oliguria, electrolyte imbalance and other adverse reactions, which can disappear after stopping the drug and corresponding treatment in mild cases; ④ Other rare reactions include transient increase in serum transaminase, and very rare cases of jaundice, rash, arrhythmia, granulocytopenia, thrombocytopenia, etc., which can all recover after stopping the drug.

?1. Patients with known allergies to this product. 2. Patients who have asthma, urticaria or allergic reactions after taking aspirin or other non-steroidal anti-inflammatory drugs. 3. Contraindicated for the treatment of perioperative pain during coronary artery bypass grafting (CABG). 4. Patients with a history of gastrointestinal bleeding or perforation after the use of non-steroidal anti-inflammatory drugs. 5. Patients with active peptic ulcers/bleeding, or patients with recurrent ulcers/bleeding in the past. 6. Patients with severe heart failure.

Precautions for children: Not suitable for children under 16 years old. Precautions for pregnancy and lactation: This product can cross the placenta. Animal experiments showed toxicity to fetal mice, but it was not teratogenic. Pregnant and lactating women should not take it. Precautions for the elderly: This product may induce or aggravate gastrointestinal bleeding, ulcers and perforations in the elderly. Use with caution in elderly patients taking diuretics or with extracellular fluid loss.

Diclofenac can increase the plasma concentration of digoxin and lithium-containing preparations and reduce the renal excretion of methotrexate. Therefore, special caution should be exercised when used in combination with these drugs. br/Please read the instructions carefully and use according to the doctor's advice.

Keep away from light and store in a sealed container.

25mg*24s

24 months

Heilongjiang Yidahong Pharmaceutical Co., Ltd.

• Founded in:

  2021-01-12

• Address:

  No. 21-1, Gongye Street, Hulin City, Jixi City, Heilongjiang Province (declaration commitment)

• Tax NO.:

  91230781MA1CE97561

• Registered Funds:

  60 million yuan

• Email:

  Log in to view